Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A.

Abstract

Efforts to change the fate of human hematopoietic stem cells (HSCs) and progenitor cells (HPCs) in vitro have met with limited success. We hypothesized that previously utilized in vitro conditions might result in silencing of genes required for the maintenance of primitive HSCs/HPCs. DNA methylation and histone deacetylation are components of an epigenetic program that regulates gene expression. Using pharmacologic agents in vitro that might possibly interfere with DNA methylation and histone deacetylation, we attempted to maintain and expand cells with phenotypic and functional characteristics of primitive HSCs/HPCs. Human marrow CD34(+) cells were exposed to a cytokine cocktail favoring differentiation in combination with 5aza 2'deoxycytidine (5azaD) and trichostatin A (TSA), resulting in a significant expansion of a subset of CD34(+) cells that possessed phenotypic properties as well as the proliferative potential characteristic of primitive HSCs/HPCs. In addition, 5azaD- and TSA-pretreated cells but not the CD34(+) cells exposed to cytokines alone retained the ability to repopulate immunodeficient mice. Our findings demonstrate that 5azaD and TSA can be used to alter the fate of primitive HSCs/HPCs during in vitro culture.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2003-07-2431

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 2

  1. Cross MA, Enver T. The lineage commitment of haematopoietic progenitor cells. Curr Opin Genet Dev. 1997;5: 609-613.
  2. Danet G, Lee H, Luongo J, et al. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion. Exp Hematol. 2001;29: 1465-1473. · DOI

Cited by

See all 199

Metadata

Authors
Milhem, M., Mahmud, N., Lavelle, D., Araki, H., DeSimone, J., Saunthararajah, Y., & Hoffman, R.
Affiliations
University of Illinois Chicago (US)
Venue
Blood
Published
2004-06-01
Volume
103
Issue
11
Pages
4102-4110
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2005852731
Cited by
195
References
41
Citations by year
2025: 3 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 6 · 2018: 5 · 2017: 11 · 2016: 7 · 2015: 16 · 2014: 10 · 2013: 8 · 2012: 12
FWCI
9.86
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
hematopoietic stem cells, hematopoietic progenitor cells, decitabine, trichostatin A, DNA methylation, histone deacetylation, epigenetic reprogramming, CD34+ cells, in vitro expansion, repopulation
MeSH terms
Decitabine, Adult, Antimetabolites, Antineoplastic, Azacitidine, Cell Division, Cells, Cultured, Hematopoietic Stem Cells, Humans, Hydroxamic Acids, Methylation, Phenotype, Protein Synthesis Inhibitors, Thy-1 Antigens, Antigens, CD34, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A. https://app.cochat.ai/papers/10.1182/blood-2003-07-2431
The paper
Milhem, M., Mahmud, N., Lavelle, D., Araki, H., DeSimone, J., Saunthararajah, Y., & Hoffman, R. (2004). Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A. Blood. https://doi.org/10.1182/blood-2003-07-2431

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.